columbia_logo
what is buprenorphine
about the buprenorphine program
request more information
about our staff
glossary of terms
transportation information
schedule an appointment
contact us

About Our Staff

Herbert D. Kleber, M.D.
Professor of Psychiatry
Director, Division on Substance Abuse

Dr. Kleber is the Director of the Division on Substance Abuse at the NYS Psychiatric Institute. He has been in the substance abuse field for over 35 years and is the author of over 200 scientific articles and books on this subject. Dr. Kleber is an international expert on the treatment of opiate dependence and is listed in Best Doctors in America and New York City.

David M. McDowell, M.D.
Director, Buprenorphine Program
Dr. McDowell is Senior Medical Director of the Substance Treatment and Research Service of the NYS Psychiatric Institute and the author of numerous scholarly and popular articles on psychiatry and substance abuse.

Erik W. Gunderson, M.D.
Medical Director, Buprenorphine Program
Dr. Gunderson trained in internal medicine at Mt. Sinai Medical Center in New York City where he also served as Chief Resident. He completed a Substance Abuse Fellowship at Columbia University College of Physicians and Surgeons and is ABIM and ASAM certified.